Stay updated on Intranasal Ketamine in Autism Social Impairment Clinical Trial
Sign up to get notified when there's something new on the Intranasal Ketamine in Autism Social Impairment Clinical Trial page.

Latest updates to the Intranasal Ketamine in Autism Social Impairment Clinical Trial page
- Check2 days agoNo Change Detected
- Check9 days agoChange DetectedThe only visible change is the revision label updated from Revision: v3.3.3 to Revision: v3.3.4. No study content, data, or user-facing information was altered. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.1%

- Check16 days agoNo Change Detected
- Check30 days agoChange DetectedAdded a Locations section with Ohio as the study site. Removed the Ohio Locations and HHS Vulnerability Disclosure items; page revision updated to v3.3.3.SummaryDifference0.2%

- Check59 days agoChange DetectedRevision: v3.3.2 added and v3.2.0 removed.SummaryDifference0.1%

- Check66 days agoChange DetectedThe government funding operating-status banner was removed from the page. Core study details, eligibility criteria, and outcome measures remain unchanged.SummaryDifference0.4%

- Check81 days agoChange DetectedThe screenshots indicate cosmetic layout and formatting updates to the Study Details page without changes to core trial data such as eligibility criteria, enrollment, locations, and outcomes. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.4%

- Check109 days agoChange DetectedAdded a government-status notice and a v3.2.0 revision; removed the v3.1.0 revision. The page now informs users about potential delays and where to check current operating status, and indicates the new version.SummaryDifference5%

Stay in the know with updates to Intranasal Ketamine in Autism Social Impairment Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Intranasal Ketamine in Autism Social Impairment Clinical Trial page.